ClinicalTrials.gg
CompletedNCT03635151Updated Apr 18, 2024Results posted

Caregiver Self-Management Needs Through Skill-Building

An interventional study of Telephone Assessment and Skill-Building Kit (TASK III) Group and Information Support and Referral (ISR) Group in Family Caregivers and Stroke, sponsored by University of Cincinnati. Completed at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-18.

Sponsored by University of Cincinnati · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Apr 2018, registered Jul 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
74
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

Caring for a family member after a stroke can be very difficult and worsen the physical and mental health of untrained caregivers. The Telephone Assessment and Skill-Building Kit (TASK III) intervention is a unique, comprehensive caregiver intervention program that enables caregivers to develop the necessary skills to manage care for the survivor, while also taking care of themselves. The long-term goal of this study is to offer training and support for family caregivers through an efficacious, cost-effective program.

Read the detailed description

Stroke is a leading cause of serious, long-term disability, and has a very sudden onset; families are often thrust into providing care without any training from health care providers. Studies have shown that caregiving without training can be detrimental to caregiver's physical and mental health, which can impede survivor rehabilitation and lead to institutionalization and higher societal costs. Unlike existing stroke caregiver interventions that require costly face to face interactions, and that focus primarily on the survivor's care, the Telephone Assessment and Skill-Building Kit (TASK II) is delivered completely by telephone, and empowers caregivers to address both their own and the survivor's needs using innovative skill-building strategies. Aligned with current patient and caregiver guidelines, TASK II has demonstrated evidence of content validity, treatment fidelity, caregiver satisfaction, and efficacy for reducing depressive symptoms; however, future development of TASK II requires a stronger focus on self-management strategies to improve caregiver health, and enhanced use of other telehealth modes of delivery prior to implementation into ongoing stroke systems of care. The purpose of this study is to optimize the TASK III intervention through the innovative leveraging of technologies and theoretically-based self-management strategies to improve caregiver health. Specific Aim 1 consists of focus groups and individual interviews with 40 experts (10 interdisciplinary researchers, 10 technology experts, 10 clinicians and clinical leaders, and 10 stroke family caregivers) to provide preferences about essential areas of new self-management content, proposed technologies (e.g., iBook, eBook, interactive website, FaceTime, Zoom), and future implementation strategies to inform a novel TASK III prototype. Specific Aim 2 will determine feasibility of the TASK III intervention with a pilot study of 74 stroke caregivers randomized to TASK III or an Information, Support, and Referral (ISR) group in preparation for a larger randomized controlled clinical trial. Recruitment, retention, treatment fidelity, satisfaction, and technology ratings will be obtained for both TASK III and ISR groups who will receive 8 weekly sessions with a booster session 4 weeks later. Outcome measures will be explored at baseline, 8 weeks (end of intervention), and 12 weeks (after booster). If TASK III is shown to be efficacious in a future randomized controlled clinical trial, our next goal will be to translate TASK III into ongoing stroke systems of care; and, someday to adapt it for use among caregivers with other debilitating/chronic conditions providing a tremendous public health impact.

02

Conditions studied

  • Family Caregivers
  • Stroke

Browse trials for

Keywords

  • Clinical trial
03

In context

Stroke

7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's enrollment of 74 is above the median of 50 across 5,482 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Cincinnati is the lead sponsor of 324 studies on the registry; 42 are open to participants now.

Of its 24 completed or terminated interventional studies of FDA-regulated products, 15 (63%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 21 years or older
  • Primary caregiver (unpaid family member or significant other providing care for a stroke survivor)
  • Must be providing care after discharge to the home setting (for Specific Aim 2)
  • Fluent in the English language
  • Access to telephone or computer
  • No difficulties hearing or talking by telephone or computer
  • (Specific Aim 1) Willing to participate in an online or telephone focus group or an online or telephone individual interview. Some interviews or focus groups may be offered face to face.
  • (Specific Aim 2) Willing to participate in 9 calls from a nurse and 3 data collection interviews.

Exclusion criteria

Exclusion Criteria:

Excluded if the survivor:

  • Had not had a stroke
  • Did not need help from the caregiver
  • Was going to reside in a nursing home or long-term care facility

Excluded if the caregiver:

  • Scores \<16 on the Oberst Caregiving Burden Scale Task Difficulty Subscale (for Specific Aim 2)
  • Scores \< 4 on a 6-item cognitive impairment screener.

Excluded if the caregiver or survivor is:

  • Prisoner or on house arrest
  • Pregnant
  • Terminal illness (e.g., late stage cancer, end-of-life condition, renal failure requiring dialysis)
  • History of Alzheimer's, dementia, or severe mental illness (e.g., suicidal tendencies, schizophrenia, severe untreated depression or manic depressive disorder)
  • History of hospitalization for alcohol or drug abuse
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
74 participants (actual)

Study arms

  • Experimental
    TASK III Group

    The Telephone Assessment and Skill-Building Kit (TASK III) group

    Behavioral: Telephone Assessment and Skill-Building Kit (TASK III) Group

  • Active comparator
    ISR Group

    The Information, Support, and Referral (ISR) group

    Behavioral: Information Support and Referral (ISR) Group

Interventions

  • BehavioralTelephone Assessment and Skill-Building Kit (TASK III) Group

    The TASK III group will receive a TASK III Resource Guide that we developed and 8 weekly calls from a nurse. The nurse will call again a month later. The TASK III nurse will help you assess your needs and concerns, build your skills as a caregiver, and refer you to community resources.

  • BehavioralInformation Support and Referral (ISR) Group

    The ISR group will receive an American Heart Association brochure and 8 weekly calls from a nurse. The nurse will call again a month later. The ISR nurse will provide information, support, and referral to community resources.

06

What researchers measure

Primary outcomes

  1. Caregiver Satisfaction Ratings for Both TASK III and ISR Programs Measured by the Caregiver Satisfaction Scale (CSS).

    Caregiver satisfaction ratings (usability, ease of use, acceptability) for both TASK III and ISR programs are measured using the Caregiver Satisfaction Scale (CSS). The CSS consists of 9 items rated on a response scale ranging from 1 = Strongly Disagree to 5 = Strongly Agree. Items are summed for a total score, then divided by 9 (number of items) with a possible range of 1 to 5. Higher scores indicate greater satisfaction.

    Time frame: 12 weeks

Secondary outcomes

  1. Depressive Symptoms Measured by the Patient Health Questionnaire Depression Scale (PHQ-9).

    Caregiver depressive symptoms are measured by the Patient Health Questionnaire Depression Scale (PHQ-9) consisting of 9 items rated on a response scale ranging from 0 = Not at all to 3 = Nearly every day. Items are summed for a total score with a possible range of 0 to 27. Higher scores indicate higher depressive symptoms.

    Time frame: Assessed at Baseline, Week 8, and Week 12, change from Baseline to Week 8 Reported.

  2. Life Changes (i.e., Changes in Social Functioning, Subjective Well-being, and Physical Health as a Result of Providing Care) Measured by the Bakas Caregiving Outcomes Scale (BCOS).

    Caregiver life changes (i.e., changes in social functioning, subjective well-being, and physical health as a result of providing care) are measured by the Bakas Caregiving Outcomes Scale (BCOS). The BCOS consists of 15 items rated on a response scale ranging from -3 (changed for the worst) to +3 (Changed for the best). The items are recoded (-3 = 1) (-2 = 2) (-1 = 3) (0 = 4) (1 = 5) (2 = 6) (3 = 7) so that positive numbers can be obtained for analysis. The recoded responses to the 15 items are summed for a total score with a possible range of 15-105. Higher scores indicate more positive life changes as a result of providing care.

    Time frame: Assessed at Baseline, Week 8, and Week 12, change from Baseline to Week 8 Reported.

  3. Unhealthy Days Measured by the Number of Unhealthy Days in the Past 30 Days.

    Caregiver unhealthy days are measured using the Unhealthy Days (UD) measure consisting of two items: How many days during the past 30 days was your physical health not good?; How many days during the past 30 days was your mental health not good? These items range from 0 = no unhealthy days to 30 = 30 unhealthy days. The two items are summed for a total score, with a cap of 30 days. Higher scores indicate more unhealthy days in the past 30 days.

    Time frame: Assessed at Baseline, Week 8, and Week 12, change from Baseline to Week 8 Reported.

07

Results

Posted Apr 18, 2024

Participant flow

Participant flow — Overall Study
MilestoneTASK III GroupISR Group
Started3638
Completed3134
Not completed54

Outcome measures

PrimaryCaregiver Satisfaction Ratings for Both TASK III and ISR Programs Measured by the Caregiver Satisfaction Scale (CSS).

Caregiver satisfaction ratings (usability, ease of use, acceptability) for both TASK III and ISR programs are measured using the Caregiver Satisfaction Scale (CSS). The CSS consists of 9 items rated on a response scale ranging from 1 = Strongly Disagree to 5 = Strongly Agree. Items are summed for a total score, then divided by 9 (number of items) with a possible range of 1 to 5. Higher scores indicate greater satisfaction.

Time frame:
12 weeks
Reported as:
Mean · score on a scale
Caregiver Satisfaction Ratings for Both TASK III and ISR Programs Measured by the Caregiver Satisfaction Scale (CSS).
score on a scaleTASK III GroupISR Group
Caregiver Satisfaction Ratings for Both TASK III and ISR Programs Measured by the Caregiver Satisfaction Scale (CSS).4.59 ± .474.15 ± .59
SecondaryDepressive Symptoms Measured by the Patient Health Questionnaire Depression Scale (PHQ-9).

Caregiver depressive symptoms are measured by the Patient Health Questionnaire Depression Scale (PHQ-9) consisting of 9 items rated on a response scale ranging from 0 = Not at all to 3 = Nearly every day. Items are summed for a total score with a possible range of 0 to 27. Higher scores indicate higher depressive symptoms.

Time frame:
Assessed at Baseline, Week 8, and Week 12, change from Baseline to Week 8 Reported.
Reported as:
Mean · units on a scale
Depressive Symptoms Measured by the Patient Health Questionnaire Depression Scale (PHQ-9).
units on a scaleTASK III GroupISR Group
Depressive Symptoms Measured by the Patient Health Questionnaire Depression Scale (PHQ-9).-2.3 ± 0.7-0.6 ± 0.7
SecondaryLife Changes (i.e., Changes in Social Functioning, Subjective Well-being, and Physical Health as a Result of Providing Care) Measured by the Bakas Caregiving Outcomes Scale (BCOS).

Caregiver life changes (i.e., changes in social functioning, subjective well-being, and physical health as a result of providing care) are measured by the Bakas Caregiving Outcomes Scale (BCOS). The BCOS consists of 15 items rated on a response scale ranging from -3 (changed for the worst) to +3 (Changed for the best). The items are recoded (-3 = 1) (-2 = 2) (-1 = 3) (0 = 4) (1 = 5) (2 = 6) (3 = 7) so that positive numbers can be obtained for analysis. The recoded responses to the 15 items are summed for a total score with a possible range of 15-105. Higher scores indicate more positive life changes as a result of providing care.

Time frame:
Assessed at Baseline, Week 8, and Week 12, change from Baseline to Week 8 Reported.
Reported as:
Mean · units on a scale
Life Changes (i.e., Changes in Social Functioning, Subjective Well-being, and Physical Health as a Result of Providing Care) Measured by the Bakas Caregiving Outcomes Scale (BCOS).
units on a scaleTASK III GroupISR Group
Life Changes (i.e., Changes in Social Functioning, Subjective Well-being, and Physical Health as a Result of Providing Care) Measured by the Bakas Caregiving Outcomes Scale (BCOS).11.2 ± 2.63.1 ± 2.4
SecondaryUnhealthy Days Measured by the Number of Unhealthy Days in the Past 30 Days.

Caregiver unhealthy days are measured using the Unhealthy Days (UD) measure consisting of two items: How many days during the past 30 days was your physical health not good?; How many days during the past 30 days was your mental health not good? These items range from 0 = no unhealthy days to 30 = 30 unhealthy days. The two items are summed for a total score, with a cap of 30 days. Higher scores indicate more unhealthy days in the past 30 days.

Time frame:
Assessed at Baseline, Week 8, and Week 12, change from Baseline to Week 8 Reported.
Reported as:
Mean · Days
Unhealthy Days Measured by the Number of Unhealthy Days in the Past 30 Days.
DaysTASK III GroupISR Group
Unhealthy Days Measured by the Number of Unhealthy Days in the Past 30 Days.1.93 ± 1.70-1.15 ± 1.72

Adverse events

Collected over From Baseline to Week 8 and Week 12.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
TASK III Group0/36 (0%)0/36 (0%)0/36 (0%)
ISR Group0/38 (0%)0/38 (0%)0/38 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)TASK III GroupISR GroupTotal
Mean59 ± 1356 ± 1757 ± 15
Sex: Female, Male
Sex: Female, Male(Participants)TASK III GroupISR GroupTotal
Female302959
Male6915
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)TASK III GroupISR GroupTotal
Hispanic or Latino202
Not Hispanic or Latino343872
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)TASK III GroupISR GroupTotal
American Indian or Alaska Native000
Asian022
Native Hawaiian or Other Pacific Islander000
Black or African American10919
White252752
More than one race000
Unknown or Not Reported101
Patient Health Questionnaire Depression Scale (PHQ-9)
Patient Health Questionnaire Depression Scale (PHQ-9)(units on a scale)TASK III GroupISR GroupTotal
Mean5.36 ± 6.024.95 ± 3.885.15 ± 5.01
Bakas Caregiving Outcomes Scale (BCOS)
Bakas Caregiving Outcomes Scale (BCOS)(units on a scale)TASK III GroupISR GroupTotal
Mean51.72 ± 9.7153.71 ± 12.9552.74 ± 11.45
Unhealthy Days
Unhealthy Days(Days)TASK III GroupISR GroupTotal
Mean9.03 ± 10.579.97 ± 9.089.51 ± 9.78
08

Study locations

1 site
  • University of Cincinnati College of Nursing
    Cincinnati, Ohio 45219, United States
09

References and documents

Publications

  • Bakas T, McCarthy MJ, Israel J, Brehm BJ, Dunning K, Rota M, Turner M, Miller EL. Adapting the telephone assessment and skill-building kit to the telehealth technology preferences of stroke family caregivers. Res Nurs Health. 2021 Feb;44(1):81-91. doi: 10.1002/nur.22075. Epub 2020 Oct 19. PubMed 33075163 ↗
  • Bakas T, Jones H, Israel J, Kum C, Miller EL. Designing and Evaluating a Goal-Setting Tip Sheet for Stroke Family Caregiver Health. Rehabil Nurs. 2021 Sep-Oct 01;46(5):279-288. doi: 10.1097/RNJ.0000000000000306. PubMed 33512120 ↗

Study documents

  • Protocol and statistical analysis plan · Dec 4, 2019
  • Informed consent form · Dec 4, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2018 to primary completion in Jun 2021, 38 months.

Results were first posted in Apr 2024, 2 years 9 months after primary completion.

Of 2,859 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 45. This study's 38 months is above that.

Counting every sponsor, half of 2,988 studies reached it within 23 months; a quarter within 10 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2018
First posted
Aug 17, 2018
StartActual
Apr 9, 2018
Primary completionActual
Jun 30, 2021
CompletionActual
Jun 30, 2021
Results first posted
Apr 18, 2024
Last update
Apr 18, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03635151
Responsible party
Tamilyn Bakas (Professor and Jane E. Procter Endowed Chair, University of Cincinnati) — Principal investigator
First posted
Aug 17, 2018
Start date
Apr 9, 2018
Primary completion
Jun 30, 2021
Completion
Jun 30, 2021
Results posted
Apr 18, 2024
Last update
Apr 18, 2024

Study contacts

Tamilyn Bakas, PhD, RN
principal investigator · University of Cincinnati College of Nursing

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion